Transcatheter Aortic Valve Implantation after Coronary Artery Bypass Graft

https://doi.org/10.47191/rajar/v7i10.14
Severe Aortic Stenosis, Coronary Bypass Surgery, Redo Surgery, TAVI

Authors

  • Aniss Seghrouchni Cardiovascular surgery department, Mohammed V military training hospital – Rabat – Morocco & Faculty of Medicine and Pharmacy of Fes, Sidi Mohamed Ben Abdellah University – Fes – Morocco
  • Noureddine Atmani Cardiovascular surgery department, Mohammed V military training hospital – Rabat – Morocco & Faculty of Medicine and Pharmacy of Fes, Sidi Mohamed Ben Abdellah University – Fes – Morocco
  • Younes Moutakiallah Cardiovascular surgery department, Mohammed V military training hospital – Rabat – Morocco
  • Youssef El Bekkali Cardiovascular surgery department, Mohammed V military training hospital – Rabat – Morocco
  • Mahdi Ait Houssa Cardiovascular surgery department, Mohammed V military training hospital – Rabat – Morocco
Vol. 7 No. 10 (2021): VOLUME 07 ISSUE 10
Articles
October 27, 2021
October 27, 2021

Downloads

The perioperative risk of surgical aortic valve replacement in patients with severe aortic stenosis and previous coronary artery bypass grafting (CABG) is increased. Transcatheter aortic valve implantation (TAVI) represents an alternative.

We report a case of severe aortic stenosis with an indication for native aortic valve replacement in a patient with prior quadruple bypass surgery.

The patient underwent implantation of a 29-mm Corevalve Evolut R aortic valve by left femoral catheterization (TAVI), under general anesthesia with surgical approach to the left scarpa. The procedure went well and the evolution was simple.

TAVI after coronary artery bypass grafting is an increasingly proposed alternative procedure with excellent results in high-risk surgical patients with severe calcified aortic stenosis.